{"count": 1, "results": [{"_id": "36428695", "pmid": 36428695, "pmcid": "PMC9688202", "title": "Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma", "journal": "Cancers (Basel)", "authors": ["Santos JC", "Profitós-Pelejà N", "Ribeiro ML", "Roué G"], "date": "2022-11-15T00:00:00Z", "doi": "10.3390/cancers14225601", "meta_date_publication": "2022 Nov 15", "meta_volume": "14", "meta_issue": "22", "meta_pages": "", "score": 50257.535, "text_hl": "The effective impairment of @DISEASE_Lymphoma_Mantle_Cell @DISEASE_MESH:D020522 @@@MCL@@@ cell survival was accompanied by the inhibition of @GENE_AKT1 @GENE_207 @@@AKT@@@ and @GENE_MTOR @GENE_419455 @@@mTOR@@@ phosphorylation. Moreover, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ strongly decreased @DISEASE_Lymphoma_Mantle_Cell @DISEASE_MESH:D020522 @@@MCL@@@ cell migration and invasion ability, leading to a 55% @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ growth inhibition and a consistent diminution of @<m>DISEASE_Bone_Marrow_Diseases</m> @DISEASE_MESH:D001855 @@@bone marrow and spleen metastasis@@@ in vivo. ", "citations": {"NLM": "Santos JC, Profitós-Pelejà N, Ribeiro ML, Roué G. Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma Cancers (Basel). 2022 Nov 15;14(22):. PMID: 36428695", "BibTeX": "@article{36428695, title={Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma}, author={Santos JC and Profitós-Pelejà N and Ribeiro ML and Roué G}, journal={Cancers (Basel)}, volume={14}, number={22}}"}}]}